Case ReportVerruconis Gallopava Recurrent Infection in a Renal Transplant RecipientGrewal, Harkiran K. MD; Kumar, Princy N. MD; Shah, Namrata MD; Timpone, Joseph G. MDAuthor Information From the Division of Infectious Diseases and Travel Medicine, Department of Medicine, Georgetown University Hospital, Washington, DC. Correspondence to: Harkiran Grewal, MD, Division of Infectious Diseases and Travel Medicine, Department of Medicine, Georgetown University Hospital, 3800 Reservoir Rd, NW, Washington, DC. E-mail: [email protected]. The authors have no funding or conflicts of interest to disclose. Infectious Diseases in Clinical Practice: July 2018 - Volume 26 - Issue 4 - p e12-e15 doi: 10.1097/IPC.0000000000000569 Buy Metrics AbstractIn Brief Verruconis gallopava is a neurotropic dematiaceous mold that causes a wide range of infections in immunocompromised and occasionally immunocompetent individuals. This mold has unique pathogenic characteristics. We describe a case of recurrent/relapsing V. gallopava infection in a renal transplant patient, which occurred years after transplantation. To the best of our knowledge, this is the second case of recurrent V. gallopava infection reported in the literature. We also discuss the unique clinical characteristics of this organism in solid organ transplant recipients and review current literature describing the potential treatment options for this organism. A patient with a kidney transplant developed disseminated Verruconis gallopava infection 5 years after transplantation. He was successfully treated with dual antifungal therapy, but relapsed rapidly after being off the consolidation therapy for only two weeks. This interesting case reviews the treatment options for this mold and potential need for lifelong suppressive therapy in certain populations. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.